| | |

CT Scans Fail To Identify Metastatic Mesothelioma Prior to Surgery

CT scans

CT scans are not a reliable way to detect the spread of mesothelioma into certain lymph nodes between the ribs. This is important because people with mesothelioma cells in their posterior intercostal lymph nodes (PILN) do not tend to get good results from P/D surgery.

Surgeons need a good way to find mesothelioma cells in these lymph nodes before they decide to perform this risky operation. But University of Pennsylvania researchers say CT scans are not the best method. 

CT Scans in Mesothelioma Diagnosis and Prognosis

CT stands for computerized tomography. A CT machine uses a series of X-ray images from different angles to create a 3D picture of a mesothelioma tumor. Most hospitals have a CT scanner. They are more common than PET or MRI machines. 

CT scans are one of the main ways that doctors identify cancer. They use a combination of imaging scans, exams, biomarker tests, and patient history to make a mesothelioma diagnosis. CT scans can also show if a treatment is working. 

But CT scans have limitations, too. A CT image may show a tumor as a dark mass. But it is not always possible to tell from the picture if the mass is cancer. Doctors often combine computed tomography with PET scanning for better results. 

Metastatic PILN and P/D Surgery

Pleurectomy with decortication (P/D) is one of the two main types of surgery for mesothelioma. Surgeons remove the diseased pleural membrane and other at-risk tissues. 

The posterior intercostal lymph nodes are toward the back of the chest, between the ribs. Research shows that people whose mesothelioma is already in the PILN have shorter survival after P/D surgery.

The new study tests the value of CT scans for finding metastatic PILN before surgery. Thirty-six patients underwent extended P/D surgery for pleural mesothelioma between 2007 and 2013. 

Comparing CT and Pathology

During surgery, doctors discovered that 22 patients had mesothelioma cells in their PILN. Fourteen patients did not. Radiologists who did not know the results of surgery analysed the preoperative CT scans. 

CT scans did show some of the PILN. But most of the scans could not show if the PILN had mesothelioma cells in them.  

“The number of PILN on preoperative CT did not predict metastasis with an average of 2 PILN seen, regardless of PILN pathology,” states the report in Lung Cancer.  

The benign and malignant PILN were about the same size. The different radiologists found about the same number and size of PILN in the CT scans.

The report concludes, “CT does not reliably identify metastatic PILN on preoperative CT for patients with malignant pleural mesothelioma undergoing extended pleurectomy/decortication.”

Source:

Berger, I, et al, “CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma”, December 4, 2020, Lung Cancer, https://www.lungcancerjournal.info/article/S0169-5002(20)30720-0/fulltext

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…